Biotech · Private company

ISA Pharmaceuticals B.V.

Track this companyFree. Adds ISA Pharmaceuticals B.V. to your Dealase workspace and tells you when its record changes.

Clinical trials30 recruiting or active

Pipeline programs0None found yet

Disclosed deals0None found yet

Cash runwayNot availablePrivate: no SEC financials

Clinical trials3

Cemiplimab and ISA101b Vaccine in Adult Participants With Recurrent/Metastatic Human Papillomavirus (HPV)16 Cervical Cancer Who Have Experienced Disease Progression After First Line ChemotherapyPHASE2 · COMPLETED · started Jun 28, 2021ClinicalTrials.gov NCT04646005 · fetched Nov 12, 2026
Utomilumab and ISA101b Vaccination in Patients With HPV-16-Positive Incurable Oropharyngeal CancerPHASE2 · TERMINATED · started Apr 4, 2018ClinicalTrials.gov NCT03258008 · fetched Nov 12, 2026
Nivolumab and HPV-16 Vaccination in Patients With HPV-16 Positive Incurable Solid TumorsPHASE2 · COMPLETED · started Dec 23, 2015ClinicalTrials.gov NCT02426892 · fetched Nov 12, 2026